(MENAFN- Ameliorate Digital Consultancy)
The latex agglutination test is a diagnostic tool used in clinical laboratories for the detection of antigens and antibodies in various body fluids such as blood, serum, urine, and cerebrospinal fluid. The test involves the use of latex particles coated with specific antibodies or antigens that react with the corresponding antigen or antibody in the sample, leading to visible agglutination. The market for latex agglutination tests is driven by the increasing prevalence of infectious diseases, growing demand for point-of-care testing, and the development of advanced technologies for rapid and accurate diagnosis.
Global revenue from the latex agglutination test market is estimated at around US$ 2.4 Bn for 2022, with the market predicted to move ahead at a CAGR of 5.6% and reach a valuation of around US$ 4.1 Bn by the end of 2032.
Request For Free Sample Report of“Latex Agglutination Test Market” @
The market is driven by several factors, including the increasing prevalence of infectious diseases, the growing demand for point-of-care testing, and the development of advanced technologies for rapid and accurate diagnosis.
The latex agglutination test market can be segmented based on product type, application, end-user, and geography. Based on product type, the market can be segmented into kits and reagents. Based on application, the market can be segmented into infectious disease diagnosis, autoimmune disease diagnosis, and others. Based on end-user, the market can be segmented into hospitals, diagnostic laboratories, and others.
Companies
Thermo Fisher Scientific bioMérieux SA Atlas Medical GmbH Mira Vista Labs Lorne Laboratories Limited Bio-Rad Laboratories, Inc. Calbiotech Eurofins Technologies Beckman Coulter, Inc. Hardy Diagnostics Geneilabs Mast Group Ltd. Lab Care Diagnostics (India) Pvt. Ltd. Ngaio Diagnostics
Buy Full Report Now @
The kits segment is expected to hold the largest share of the latex agglutination test market during the forecast period. This is due to the increasing demand for ready-to-use test kits in diagnostic laboratories and hospitals.
The infectious disease diagnosis segment is expected to hold the largest share of the latex agglutination test market during the forecast period. This is due to the increasing prevalence of infectious diseases worldwide and the growing demand for rapid and accurate diagnostic tools for the detection of these diseases.
Geographically, the latex agglutination test market can be segmented into North America, Europe, Asia Pacific, Middle East and Africa, and South America. North America is expected to hold the largest share of the market during the forecast period, followed by Europe and Asia Pacific. This is due to the high prevalence of infectious diseases in these regions and the increasing demand for point-of-care testing.
Competitive Landscape
Leading manufacturers are developing cutting-edge technologies and diagnostic techniques to bolster their product lines. Consolidation efforts have been made by several significant competitors in the latex agglutination sector to advance research and development.
For instance:
In October 2022, at the Association for Molecular Pathology's (AMP) 2022 annual meeting and exhibition, held from November 1 to 5, at the Phoenix Convention Center, Thermo Fisher Scientific, an industry pioneer in providing science services, displayed its most cutting-edge creative research and diagnostic technologies. In January 2022, a wide variety of native viral antigens were released by Creative Diagnostics, a market leader in providing raw materials, antibodies, and reagents to the biotechnology industry. These antigens are perfect building blocks for the creation of infectious disease kits and reagents.
Request Customization @
Segmentation of Latex Agglutination Test Industry Research
By Test Type:
LAT for Antigen Detection LAT for Antibody Detection
By Sample Type:
Blood/Plasma Cerebrospinal Fluid (CSF) Urine Sperm Others
By Application:
By Indication:
C-reactive protein (CRP) Bacterial Meningitis Rheumatoid Arthritis (RA) Staphylococcus aureus E.coli Others
By End User:
Hospitals Diagnostic laboratories Academic & Research Institutes
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
Contact Us:
Persistence Market Research
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –